NDC 71335-3088-04 - Hydroxyzine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-3088
- Requested NDC
- 71335-3088-04
- Package NDCs from labels
- 71335-3088-1, 71335-3088-2, 71335-3088-3, 71335-3088-4, 71335-3088-5, 71335-3088-6, 71335-3088-7, 71335-3088-8, 71335-3088-04
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydroxyzine Hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-3088-1 | Hydroxyzine Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 71335-3088-2 | Hydroxyzine Hydrochloride | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 1 | |
| 71335-3088-3 | Hydroxyzine Hydrochloride | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 1 | |
| 71335-3088-4 | Hydroxyzine Hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 1 | |
| 71335-3088-5 | Hydroxyzine Hydrochloride | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | 1 | |
| 71335-3088-6 | Hydroxyzine Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 1 | |
| 71335-3088-7 | Hydroxyzine Hydrochloride | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 1 | |
| 71335-3088-8 | Hydroxyzine Hydrochloride | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.